Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Controlled comparison of two moxifloxacin containing treatment shortening regimens with the standard regimen in pulmonary TB
Study Director
Start Date
1 / 2008
Trial Phase
Trial Status
all patients enrolled
Current Enrollment
Target Enrollment
2400
Overview
Compound Associations
Moxifloxacin for Drug-Sensitive TB